Delivery Order SPE2DB20D3101-SPE2DB25FRSW8
Award Date 8/18/25
Potential Completion Date 8/19/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,262.40 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used to restore function to central venous catheters. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and was competitively awarded without set-aside restrictions. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,374.60 for Cathflo Activase 2 mg vials, effective July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price delivery order was awarded without a set-aside designation through open competition and will be performed at the contractor's Conshohocken, Pennsylvania facility. Cathflo Activase is a thrombolytic agent used in medical settings to restore function to occluded...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,558.77 by the Defense Logistics Agency on July 21, 2025, for the supply of Cathflo Activase 2 mg vials. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The ultimate completion date is scheduled for July 22, 2025, with performance occurring at the contractor's Conshohocken...
- The Defense Logistics Agency awarded a delivery order valued at $5,429.76 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials. This firm fixed-price contract, with an ultimate completion date of August 19, 2025, represents a pediatric thrombolytic medication used in medical settings to restore blood flow in occluded central venous catheters. The award was made on a competitive basis with no set-aside designation, and performance will take place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,949.43 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials under a firm fixed-price contract. This non-set-aside award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a routine pharmaceutical procurement from the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $16,297.10 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used in medical applications. The contract was executed as a firm fixed-price delivery order on July 31, 2025, with an ultimate completion date of August 1, 2025, and does not include a set-aside designation. Performance will be fulfilled at the vendor's facility in Conshohocken, Pennsylvania. This delivery order...
- This delivery order, valued at $4,524.80, was awarded to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cathflo Activase 2 mg vials. The contract is a firm fixed price, non-set-aside award funded by the Defense Logistics Agency (DLA) and is scheduled for completion by July 21, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under the company's broader pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 4,565,249,124 units of the pharmaceutical product Cathflo Activase (2 mg vials), with a ceiling value of $2,570.16. The contract has a firm fixed price pricing type and no set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Cathflo Activase 2 mg vials. The contract has a ceiling value of $2,570.16 and a period of performance through March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded...
- This delivery order, issued on August 7, 2025, awards AmerisourceBergen Drug Corp $1,696.80 for the supply of Cathflo Activase 2 mg vials under a firm fixed price contract. The award is funded by the Defense Logistics Agency, a defense-focused component of the Department of Defense responsible for supplying medical and pharmaceutical commodities to military and veteran healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...